Psychiatric polygenic risk scores: Child and adolescent psychiatrists' knowledge, attitudes, and experiences

IF 1.6 3区 医学 Q3 GENETICS & HEREDITY
Stacey Pereira, Katrina A. Muñoz, Brent J. Small, Takahiro Soda, Laura N. Torgerson, Clarissa E. Sanchez, Jehannine Austin, Eric A. Storch, Gabriel Lázaro-Muñoz
{"title":"Psychiatric polygenic risk scores: Child and adolescent psychiatrists' knowledge, attitudes, and experiences","authors":"Stacey Pereira,&nbsp;Katrina A. Muñoz,&nbsp;Brent J. Small,&nbsp;Takahiro Soda,&nbsp;Laura N. Torgerson,&nbsp;Clarissa E. Sanchez,&nbsp;Jehannine Austin,&nbsp;Eric A. Storch,&nbsp;Gabriel Lázaro-Muñoz","doi":"10.1002/ajmg.b.32912","DOIUrl":null,"url":null,"abstract":"<p>Psychiatric polygenic risk scores (PRS) have potential utility in psychiatric care and prevention, but there are concerns about their implementation. We surveyed 960 US-based practicing child and adolescent psychiatrists' (CAP) about their experiences, perspectives, and potential uses of psychiatric PRS. While 23% of CAP reported that they had never heard of PRS, 10 % of respondents have had a patient/family bring PRS to them and 4% have generated PRS for patients. Though 25% stated they would request PRS if a patient/caregiver asked, 35% indicated that nothing would prompt them to request PRS. Most respondents (54%) believed psychiatric PRS are currently at least slightly useful and 87% believed they will be so in 5 years. More than 70% indicated they would take action in response to a child with a top fifth percentile psychiatric PRS but no diagnosis: 48% would increase monitoring of symptoms, 42% would evaluate for current symptoms, and 4% would prescribe medications. Yet, most respondents were concerned that high-PRS results could lead to overtreatment and negatively impact patients' emotional well-being. Findings indicate emerging use of psychiatric PRS within child and adolescent psychiatry in the US. It is critical to examine the ethical and clinical challenges that PRS may generate and begin efforts to promote their informed and responsible use.</p>","PeriodicalId":7673,"journal":{"name":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","volume":"189 7-8","pages":"293-302"},"PeriodicalIF":1.6000,"publicationDate":"2022-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ajmg.b.32912","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 3

Abstract

Psychiatric polygenic risk scores (PRS) have potential utility in psychiatric care and prevention, but there are concerns about their implementation. We surveyed 960 US-based practicing child and adolescent psychiatrists' (CAP) about their experiences, perspectives, and potential uses of psychiatric PRS. While 23% of CAP reported that they had never heard of PRS, 10 % of respondents have had a patient/family bring PRS to them and 4% have generated PRS for patients. Though 25% stated they would request PRS if a patient/caregiver asked, 35% indicated that nothing would prompt them to request PRS. Most respondents (54%) believed psychiatric PRS are currently at least slightly useful and 87% believed they will be so in 5 years. More than 70% indicated they would take action in response to a child with a top fifth percentile psychiatric PRS but no diagnosis: 48% would increase monitoring of symptoms, 42% would evaluate for current symptoms, and 4% would prescribe medications. Yet, most respondents were concerned that high-PRS results could lead to overtreatment and negatively impact patients' emotional well-being. Findings indicate emerging use of psychiatric PRS within child and adolescent psychiatry in the US. It is critical to examine the ethical and clinical challenges that PRS may generate and begin efforts to promote their informed and responsible use.

精神病多基因风险评分:儿童和青少年精神科医生的知识、态度和经验。
精神病多基因风险评分(PRS)在精神病护理和预防方面具有潜在的实用性,但其实施仍存在问题。我们调查了960名美国执业儿童和青少年精神科医生(CAP),了解他们对精神病PRS的经验、观点和潜在用途。23%的CAP报告称他们从未听说过PRS,10%的受访者让患者/家人给他们带来了PRS,4%的受访者为患者生成了PRS。尽管25%的人表示,如果患者/护理人员提出要求,他们会要求PRS,但35%的人表示没有什么会促使他们要求PRS。大多数受访者(54%)认为精神病PRS目前至少稍微有用,87%的人认为5年后会有用 年。超过70%的人表示,他们会对患有最高百分之五精神PRS但没有诊断的儿童采取行动:48%的人会加强对症状的监测,42%的人会评估当前症状,4%的人会开药。然而,大多数受访者担心高PRS结果可能导致过度治疗,并对患者的情绪健康产生负面影响。研究结果表明,在美国儿童和青少年精神病学中,精神病PRS的使用正在兴起。检查PRS可能产生的伦理和临床挑战,并开始努力促进其知情和负责任的使用,这一点至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.90
自引率
7.10%
发文量
40
审稿时长
4-8 weeks
期刊介绍: Neuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG) , provides a forum for experimental and clinical investigations of the genetic mechanisms underlying neurologic and psychiatric disorders. It is a resource for novel genetics studies of the heritable nature of psychiatric and other nervous system disorders, characterized at the molecular, cellular or behavior levels. Neuropsychiatric Genetics publishes eight times per year.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信